Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

Gene expression signatures predictive of bevacizumab/erlotinib therapeutic benefit in advanced non-squamous non-small cell lung cancer patients (SAKK 19/05 trial).

Franzini A, Baty F, Macovei II, Durr O, Droege C, Betticher D, Grigoriu BD, Klingbiel D, Zappa F, Brutsche M.

Clin Cancer Res. 2015 Apr 28. pii: clincanres.3135.2014. [Epub ahead of print]

PMID:
25922429
2.

[The role of chronic or transient hypoxia on the retinal nerve fiber layers].

Spahr Y, Brutsche M, Valmaggia C.

Klin Monbl Augenheilkd. 2015 Apr;232(4):395-8. doi: 10.1055/s-0035-1545751. Epub 2015 Apr 22. German.

PMID:
25902085
3.

Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09.

Gautschi O, Mach N, Rothschild SI, Li Q, Stahel RA, Zippelius A, Cathomas R, Früh M, Betticher DC, Peters S, Rauch D, Feilchenfeldt J, Bubendorf L, Savic S, Jaggi R, Leibundgut EO, Largiadèr C, Brutsche M, Pilop C, Stalder L, Pless M, Ochsenbein AF; Swiss Group for Clinical Cancer Research.

Clin Lung Cancer. 2015 Mar 5. pii: S1525-7304(15)00060-1. doi: 10.1016/j.cllc.2015.02.007. [Epub ahead of print]

PMID:
25843489
4.

[ARDS after Incidental Aspiration of Petroleum in an Adult.]

Horvath CM, Schneider T, Kluckert T, Brutsche MH.

Pneumologie. 2015 Jan 28. [Epub ahead of print] German.

PMID:
25629261
5.

Impact of comorbidities on physical activity in COPD.

Sievi NA, Senn O, Brack T, Brutsche MH, Frey M, Irani S, Leuppi JD, Thurnheer R, Franzen D, Kohler M, Clarenbach CF.

Respirology. 2015 Apr;20(3):413-8. doi: 10.1111/resp.12456. Epub 2015 Jan 6.

PMID:
25565363
6.

Accuracy of the hospital anxiety and depression scale for identifying depression in chronic obstructive pulmonary disease patients.

Nowak C, Sievi NA, Clarenbach CF, Schwarz EI, Schlatzer C, Brack T, Brutsche M, Frey M, Irani S, Leuppi JD, Rüdiger J, Thurnheer R, Kohler M.

Pulm Med. 2014;2014:973858. doi: 10.1155/2014/973858. Epub 2014 Dec 4.

7.

Physical activity and the frequency of acute exacerbations in patients with chronic obstructive pulmonary disease.

Schönmann M, Sievi NA, Clarenbach CF, Brack T, Brutsche M, Frey M, Irani S, Leuppi JD, Ruediger J, Senn O, Thurnheer R, Kohler M.

Lung. 2015 Feb;193(1):63-70. doi: 10.1007/s00408-014-9673-7. Epub 2014 Dec 13.

PMID:
25503750
8.

Oxygen kinetics during 6-minute walk tests in patients with cardiovascular and pulmonary disease.

Kern L, Condrau S, Baty F, Wiegand J, van Gestel AJ, Azzola A, Tamm M, Brutsche M.

BMC Pulm Med. 2014 Oct 29;14:167. doi: 10.1186/1471-2466-14-167.

9.

Cardiopulmonary and gas-exchange responses during the six-minute walk test in patients with chronic obstructive pulmonary disease.

van Gestel AJ, Baty F, Rausch-Osthof AK, Brutsche MH.

Respiration. 2014;88(4):307-14. doi: 10.1159/000365997. Epub 2014 Sep 9.

PMID:
25227115
10.

Comprehensive biomarker profiling in patients with obstructive sleep apnea.

Maeder MT, Strobel W, Christ M, Todd J, Estis J, Wildi K, Thalmann G, Hilti J, Brutsche M, Twerenbold R, Rickli H, Mueller C.

Clin Biochem. 2015 Mar;48(4-5):340-6. doi: 10.1016/j.clinbiochem.2014.09.005. Epub 2014 Sep 16.

PMID:
25218814
11.

The outcome of community-acquired pneumonia in patients with chronic lung disease: a case-control study.

Dusemund F, Chronis J, Baty F, Albrich WC, Brutsche MH.

Swiss Med Wkly. 2014 Sep 3;144:w14013. doi: 10.4414/smw.2014.14013. eCollection 2014.

12.

Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).

Joerger M, Baty F, Früh M, Droege C, Stahel RA, Betticher DC, von Moos R, Ochsenbein A, Pless M, Gautschi O, Rothschild S, Brauchli P, Klingbiel D, Zappa F, Brutsche M.

Lung Cancer. 2014 Aug;85(2):306-13. doi: 10.1016/j.lungcan.2014.04.014. Epub 2014 May 29.

PMID:
24928469
13.

Significant reduction of AECOPD hospitalisations after implementation of a public smoking ban in Graubunden, Switzerland.

Dusemund F, Baty F, Brutsche MH.

Tob Control. 2014 Feb 5. doi: 10.1136/tobaccocontrol-2013-051290. [Epub ahead of print]

PMID:
24500271
14.

Midregional pro-adrenomedullin and copeptin: exercise kinetics and association with the cardiopulmonary exercise response in comparison to B-type natriuretic peptide.

Zurek M, Maeder MT, Brutsche MH, Lüthi A, Twerenbold R, Freese M, Rickli H, Mueller C.

Eur J Appl Physiol. 2014 Apr;114(4):815-24. doi: 10.1007/s00421-013-2815-4. Epub 2014 Jan 5.

PMID:
24390725
15.

Baseline predictors of adherence to positive airway pressure therapy for sleep apnea: a 10-year single-center observational cohort study.

Schoch OD, Baty F, Niedermann J, Rüdiger JJ, Brutsche MH.

Respiration. 2014;87(2):121-8. doi: 10.1159/000354186. Epub 2013 Nov 5.

PMID:
24216720
16.

Endobronchial ultrasound-guided transbronchial needle aspiration of an intravascular sarcoma metastasis.

Dusemund F, Schneider T, Zeisel C, Rothermundt C, Kluckert T, Schmid S, Brutsche MH.

Respiration. 2013;86(5):430-2. doi: 10.1159/000354183. Epub 2013 Sep 24.

PMID:
24081000
17.

EGFR exon-level biomarkers of the response to bevacizumab/erlotinib in non-small cell lung cancer.

Baty F, Rothschild S, Früh M, Betticher D, Dröge C, Cathomas R, Rauch D, Gautschi O, Bubendorf L, Crowe S, Zappa F, Pless M, Brutsche M; Swiss Group for Clinical Cancer Research.

PLoS One. 2013 Sep 10;8(9):e72966. doi: 10.1371/journal.pone.0072966. eCollection 2013.

18.

Characteristics of medically and surgically treated empyema patients: a retrospective cohort study.

Dusemund F, Weber MD, Nagel W, Schneider T, Brutsche MH, Schoch OD.

Respiration. 2013;86(4):288-94. doi: 10.1159/000353424. Epub 2013 Aug 27.

PMID:
23988906
19.

Exploring the transcription factor activity in high-throughput gene expression data using RLQ analysis.

Baty F, Rüdiger J, Miglino N, Kern L, Borger P, Brutsche M.

BMC Bioinformatics. 2013 Jun 6;14:178. doi: 10.1186/1471-2105-14-178.

20.

Epidermal growth factor receptor mutation in a patient with squamous cell carcinoma of the lung: who should be tested?

Schwitter M, Rodriguez R, Schneider T, Kluckert T, Brutsche M, Früh M.

Case Rep Oncol. 2013 May 14;6(2):263-8. doi: 10.1159/000351607. Print 2013 May.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk